Category Archives: Press Releases
Flywire and Mastercard Team Up to Simplify Cross-Border Tuition Payments
New promotion offers relief on tuition costs for students originating from six Middle East and African countries BOSTON, Sept. 17, 2020 (GLOBE NEWSWIRE) — Flywire, a vertical payments company, is partnering with Mastercard to provide students with discounted foreign exchange rates on cross-border tuition payments made with Mastercard. The offer is available during the 2020 […]
Hennessy’s “A World Odyssey” Presents A Daytime Explosion Event by Artist Cai Guo-Qiang
Livestreamed from Cognac to audiences worldwide, the artist’s The Birth of Tragedy honors the universal values of resilience, courage and hope PARIS, Sept. 16, 2020 /PRNewswire/ — Cai Guo-Qiang is one of the most admired artists on the contemporary art scene. In addition to his largescale, site-specific installations, Cai is particularly renowned for his unique use of […]
Gates Foundation’s Annual Goalkeepers Report Shows COVID-19 Has Stalled 20 Years of Progress, Calls for Global Response to End the Pandemic
Report shows how economic damage has reinforced inequities and derailed achievement of the UN Sustainable Development Goals; spotlights countries innovating to meet challenges SEATTLE, Sept. 15, 2020 /PRNewswire/ — The Bill & Melinda Gates Foundation today launched its fourth annual Goalkeepers Report, featuring new data showing how the ripple effects of COVID-19 have stopped 20 […]
Le rapport annuel des gardiens de but de la Fondation Gates montre que COVID-19 a bloqué 20 ans de progrès et appelle à une réponse mondiale pour mettre fin à la pandémie
Le rapport montre comment les dommages économiques ont renforcé les inégalités et fait dérailler la réalisation des objectifs de développement durable des Nations unies ; il met en lumière les pays qui innovent pour relever les défis SEATTLE, le 15 septembre 2020 /PRNewswire/ — La Fondation Bill & Melinda Gates a lancé aujourd’hui son quatrième rapport […]
RedHill Biopharma’s Opaganib Demonstrates Complete Inhibition of SARS-CoV-2
Opaganib blocks SARS-Cov-2 virus replication Opaganib completely inhibited SARS-CoV-2 viral replication as measured after three days incubation in an in vitro model of human bronchial tissue, comparing favorably with remdesivir, the positive control in the study — Opaganib is uniquely positioned as an orally-administered potential COVID-19 treatment combining potent antiviral and anti-inflammatory mechanisms of action, […]
